Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia

Journal of Inherited Metabolic Disease

Volumn 28, Issue 6, 2005, Pages 945-950

  Muhlhausen C ^a   Schneppenheim, R ^a   Budde, U ^a   Merkel, M ^a   Muschol, N ^a   Ullrich, K ^a   Santer, R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GLYCOGEN; LIPID; OLIGOMER; POLYMER; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; HYPERLIPIDEMIA; INFANT; MALE; PROTEIN BLOOD LEVEL; VASCULAR DISEASE; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; ANTIGENS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE I; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT; MALE; PROTEIN STRUCTURE, TERTIARY;

EID: 31644438875     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-005-0184-9     Document Type: Article

References (23)

1. Brown JE, Bosak JO (1986) An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 43: 303-311.
2. Chen YT (2001) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1521-1551.
3. Corby DG, Putnam CW, Greene HL (1974) Impaired platelet function in glucose-6-phosphatase deficiency. J Pediatr 85: 71-76.
4. Czapek EE, Deykin D, Salzman E (1973) Platelet dysfunction in glycogen storage disease type I. Blood 41: 235-247.
5. Dellinger TM, Livingston HM, Holder R, Streckfus CF (1998) Glycogen storage disease and von Willebrand's disease: Implications for dental treatment: Dental management of a pediatric patient. Spec Care Dentist 18: 243-246.
6. Fernandes J, Alaupovic P, Wit JM (1989) Gastric drip feeding in patients with glycogen storage disease type I: Its effects on growth and plasma lipids and apolipoproteins. Pediatr Res 25: 327-331.
7. Greene HL, Swift LL, Knapp HR (1991) Hyperlipidemia and fatty acid composition in patients treated for type Ia glycogen storage disease. J Pediatr 119: 398-403.
8. Heyne K, Hosenfeld D, Grote W, Schaub J (1984) Glycogen storage disease type Ib: Familial bleeding tendency. Eur J Pediatr 143: 7-9.
9. Hutton RA, Macnab AJ, Rivers RPA (1976) Defect of platelet function associated with chronic hypoglycaemia. Arch Dis Child 51: 49-55.
10. Jaeken J, Pirard M, Adamowicz M, Pronicka E, van Schaftingen E (1996). Inhibition of phosphomannose isomerase by fructose 1-phosphate: An explanation for defective N-glycosylation in hereditary fructose intolerance. Pediatr Res 40: 764-766.
11. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA (1995). Description of an in vitro platelet function analyser - PFA-100. Semin Thromb Hemost 21 (Supplement 2): 106-112.
12. Lee PJ, Celermajer DS, Robinson J, McCarthy SN, Betteridge DJ, Leonard JV (1994) Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 110: 95-100.
13. Marti GE, Rick ME, Sidbury J, Gralnick HR (1986) DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times. Blood 68: 180-184.
14. Mazurier C, Parquet Gernez A, Goudemand M (1977) Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willebrand's disease. Pathol Biol Paris 25: 18-24.
15. Nilsson IM, Öckerman PA (1970) The bleeding disorder in hepatomegalic forms of glycogen storage disease. Acta Paediatr Scand 59: 127-133.
16. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GPA (2002) Glycogen storage disease type I: Diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161: S20-S34.
17. Ruggeri ZM, Zimmerman TS (1981) The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57: 1140-1143.
18. Schneppenheim R, Plendl H, Budde U (1988) Luminography - an alternative assay for detection of von Willebrand factor multimers. Thromb Haemost 60: 133-136.
19. Talente GM, Coleman RA, Alter C, et al (1994) Glycogen storage disease in adults. Ann Intern Med 120: 218-226.
20. Trioche P, Francoual J, Capel L, Odiëvre M, Lindenbaum A, Labrune P (2000) Apolipoprotein E polymorphism and serum concentrations in patients with glycogen storage disease type Ia. J Inherit Metab Dis 23: 107-112.
21. Ubels FL, Rake JP, Slaets JPJ, Smit GPA, Smit AJ (2002) Is glycogen storage disease 1a associated with atherosclerosis? Eur J Pediatr 161: S62-S64.
22. Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschütter A (2002a) Radical trapping in glycogen storage disease 1a. Eur J Pediatr 161: S70-S74.
23. Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschütter A (2002b) Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 33: 103-110.